Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.
Open | $107.000 |
Close | $109.460 |
Volume / Avg. | 480.575K / 604.049K |
Day Range | 106.730 - 110.821 |
52 Wk Range | 106.605 - 146.700 |
Market Cap | $6.824B |
P/E Ratio | 17.611 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 6.04% |
Days to Cover | 4.34 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.
Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Cantor Fitzgerald on Wednesday, April 10, 2024. The analyst firm set a price target for 180.00 expecting JAZZ to rise to within 12 months (a possible 64.44% upside). 36 analyst firms have reported ratings in the last year.
The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $109.46 last updated April 26, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Jazz Pharmaceuticals.
Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for Jazz Pharmaceuticals.
Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.